Delaware
|
|
0-17085
|
|
95-3698422
|
(State
of other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
|
|
|
|
|
14272
Franklin Avenue, Tustin, California 92780
|
||||
(Address
of Principal Executive Offices)
|
||||
|
|
|
|
|
Registrant’s
telephone number, including area code: (714)
508-6000
|
||||
|
||||
Not
Applicable
|
||||
(Former
name or former address, if changed since last
report)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425).
|
o |
Soliciting
material pursuant to Rule 14A-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
(c) |
Exhibits.
|
|
|
||
PEREGRINE PHARMACEUTICALS, INC. | ||
|
|
|
Date: December 23, 2005 | By: | /s/ PAUL J. LYTLE |
|
||
Name:
Paul J. Lytle
Title:
Chief Financial Officer
|
||
Period
of
Revised
Primary Term
|
Annual
Base
Rent
|
Monthly
Base
Rent
|
|||||
Effective
Date-12/31/2006
|
$
|
745,135.44
|
$
|
62,094.62
|
|||
1/1/2007-12/31/2008
|
$
|
770,097.48
|
$
|
64,174.79
|
|||
1/1/2009-12/31/2010
|
$
|
795,895.68
|
$
|
66,324.64
|
|||
1/1/2011-12/31/2012
|
$
|
822,558.24
|
$
|
68,546.52
|
|||
1/1/2013-12/31/2014
|
$
|
850,113.96
|
$
|
70,842.83
|
|||
1/1/2015-12/31/2016
|
$
|
878,592.72
|
$
|
73,216.06
|
|||
1/1/2017-12/31/2017
|
$
|
908,025.60
|
$
|
75,668.80
|
Periods
of
1st
Extended Term
|
Annual
Base
Rent
|
Monthly
Base
Rent
|
|||||
1/1/2018-12/31/2018
|
$
|
908,025.60
|
$
|
75,668.80
|
|||
1/1/2019-12/31/2020
|
$
|
938,444.40
|
$
|
78,203.70
|
|||
1/1/2021-12/31/2022
|
$
|
969,882.24
|
$
|
80,823.52
|
Periods
of
2nd
Extended Term
|
Annual
Base
Rent
|
Monthly
Base
Rent
|
|||||
1/1/2023-12/31/2024
|
$
|
1,002,373.32
|
$
|
83,531.11
|
|||
1/1/2025-12/31/2026
|
$
|
1,035,952.80
|
$
|
86,329.40
|
|||
1/1/2027-12/31/2027
|
$
|
1,070,657.16
|
$
|
89,221.43
|
"Landlord" | TNCA,
LLC. a Delaware limited liability company |
|
|
|
|
By: |
TNCA
Holdings, LLC,
a Delaware limited liability company
Its Manager
|
|
By: | /s/ C. FREDERICK WEHBA II | |
|
||
Name:
C. Frederick Wehba II
Title:
President
|
||
Executed Date: December 22, 2005 |
"Tenant" |
PEREGRINE
PHARMACEUTICALS, INC.,
a Delaware corporation (successor-in-interest
to
Techniclone
Corporation, a Delaware corporation)
|
|
|
|
|
By: | /s/ PAUL J. LYTLE | |
|
||
Name:
Paul J. Lytle
Title:
Chief Financial Officer
|
||
Executed Date: December 22, 2005 | ||
Re: |
Repayment
of Loan
|
By: |
TNCA
Holding, LLC, a Delaware limited liability
company
|
Its Manager |
By: |
/s/
C. FREDERICK WEHBA II
|
C. Frederick Wehba II, President |
By: |
/s/
PAUL J. LYTLE
|
Paul J. Lytle, Chief Financial Officer |